These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

838 related items for PubMed ID: 23773380

  • 21. Axillary node staging for microinvasive breast cancer: is it justified?
    Lyons JM, Stempel M, Van Zee KJ, Cody HS.
    Ann Surg Oncol; 2012 Oct; 19(11):3416-21. PubMed ID: 22576061
    [Abstract] [Full Text] [Related]

  • 22. Prediction of non-sentinel lymph node involvement in breast cancer patients with a positive sentinel lymph node.
    Reynders A, Brouckaert O, Smeets A, Laenen A, Yoshihara E, Persyn F, Floris G, Leunen K, Amant F, Soens J, Van Ongeval C, Moerman P, Vergote I, Christiaens MR, Staelens G, Van Eygen K, Vanneste A, Van Dam P, Colpaert C, Neven P.
    Breast; 2014 Aug; 23(4):453-9. PubMed ID: 24768478
    [Abstract] [Full Text] [Related]

  • 23. Characteristics and outcomes of sentinel node-positive breast cancer patients after total mastectomy without axillary-specific treatment.
    Milgrom S, Cody H, Tan L, Morrow M, Pesce C, Setton J, Rogers K, Arnold B, Eaton A, Catalano J, McCormick B, Powell S, Ho A.
    Ann Surg Oncol; 2012 Nov; 19(12):3762-70. PubMed ID: 22576064
    [Abstract] [Full Text] [Related]

  • 24. Radiation field design and regional control in sentinel lymph node-positive breast cancer patients with omission of axillary dissection.
    Setton J, Cody H, Tan L, Morrow M, Hudis C, Catalano J, McCormick B, Powell S, Ho A.
    Cancer; 2012 Apr 15; 118(8):1994-2003. PubMed ID: 21882186
    [Abstract] [Full Text] [Related]

  • 25. Sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with operable breast cancer and positive axillary nodes at initial diagnosis.
    Rebollo-Aguirre AC, Gallego-Peinado M, Sánchez-Sánchez R, Pastor-Pons E, García-García J, Chamorro-Santos CE, Menjón-Beltrán S.
    Rev Esp Med Nucl Imagen Mol; 2013 Apr 15; 32(4):240-5. PubMed ID: 23684711
    [Abstract] [Full Text] [Related]

  • 26. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
    Marrazzo A, Taormina P, Gebbiab V, David M, Riili I, Lo Gerfo D, Casà L, Noto A.
    Chir Ital; 2007 Apr 15; 59(5):693-9. PubMed ID: 18019642
    [Abstract] [Full Text] [Related]

  • 27. The changing landscape of axillary surgery: which breast cancer patients may still benefit from complete axillary lymph node dissection?
    McGhan LJ, Dueck AC, Gray RJ, Wasif N, McCullough AE, Pockaj BA.
    J Surg Oncol; 2012 Sep 01; 106(3):254-9. PubMed ID: 22034211
    [Abstract] [Full Text] [Related]

  • 28. Axillary lymph node treatment in breast cancer: an update.
    Williams PA, Suggs J, Mangana SH.
    J Miss State Med Assoc; 2014 May 01; 55(5):145-7. PubMed ID: 25112128
    [Abstract] [Full Text] [Related]

  • 29. [Impact of omission of axillary dissection on adjuvant therapy in patients with metastatic sentinel lymph nodes according to the ACOSOG Z0011 criteria].
    Roosen A, Lousquy R, Bricou A, Delpech Y, Selz J, Le Maignan C, Bousquet G, Winterman S, Zelek L, Barranger E.
    Gynecol Obstet Fertil; 2014 Jun 01; 42(6):409-14. PubMed ID: 24861437
    [Abstract] [Full Text] [Related]

  • 30. Sentinel lymph node biopsy after neoadjuvant chemotherapy is accurate in breast cancer patients with a clinically negative axillary nodal status at presentation.
    Gimbergues P, Abrial C, Durando X, Le Bouedec G, Cachin F, Penault-Llorca F, Mouret-Reynier MA, Kwiatkowski F, Maublant J, Tchirkov A, Dauplat J.
    Ann Surg Oncol; 2008 May 01; 15(5):1316-21. PubMed ID: 18311507
    [Abstract] [Full Text] [Related]

  • 31. Positive versus negative sentinel nodes in early breast cancer patients: axillary or loco-regional relapse and survival. A study spanning 2000-2012.
    García Fernández A, Chabrera C, García Font M, Fraile M, Lain JM, Barco I, González C, Gónzalez S, Reñe A, Veloso E, Cassadó J, Pessarrodona A, Giménez N.
    Breast; 2013 Oct 01; 22(5):902-7. PubMed ID: 23684000
    [Abstract] [Full Text] [Related]

  • 32. Paget's disease of the breast: the experience of the European Institute of Oncology and review of the literature.
    Caliskan M, Gatti G, Sosnovskikh I, Rotmensz N, Botteri E, Musmeci S, Rosali dos Santos G, Viale G, Luini A.
    Breast Cancer Res Treat; 2008 Dec 01; 112(3):513-21. PubMed ID: 18240020
    [Abstract] [Full Text] [Related]

  • 33. Comprehensive axillary evaluation in neoadjuvant chemotherapy patients with ultrasonography and sentinel lymph node biopsy.
    Khan A, Sabel MS, Nees A, Diehl KM, Cimmino VM, Kleer CG, Schott AF, Hayes DF, Chang AE, Newman LA.
    Ann Surg Oncol; 2005 Sep 01; 12(9):697-704. PubMed ID: 16079956
    [Abstract] [Full Text] [Related]

  • 34. Patterns of Failure in Women Who Have Residual Nodal Disease After Neoadjuvant Chemotherapy for Breast Cancer According to Extent of Lymph Node Surgery.
    Kozak MM, Horst KC, Gutkin PM, Jacobson CE, Walck E, von Eyben R, Dirbas FM.
    Clin Breast Cancer; 2020 Oct 01; 20(5):431-438. PubMed ID: 32522481
    [Abstract] [Full Text] [Related]

  • 35. Completion axillary lymph node dissection for the identification of pN2-3 status as an indication for adjuvant CDK4/6 inhibitor treatment: a post-hoc analysis of the randomised, phase 3 SENOMAC trial.
    de Boniface J, Appelgren M, Szulkin R, Alkner S, Andersson Y, Bergkvist L, Frisell J, Gentilini OD, Kontos M, Kühn T, Lundstedt D, Offersen BV, Olofsson Bagge R, Reimer T, Sund M, Christiansen P, Rydén L, Filtenborg Tvedskov T, SENOMAC Trialists’ Group.
    Lancet Oncol; 2024 Sep 01; 25(9):1222-1230. PubMed ID: 39121881
    [Abstract] [Full Text] [Related]

  • 36. Omission of axillary dissection after a positive sentinel node dissection may influence adjuvant chemotherapy indications in operable breast cancer patients.
    Montemurro F, Maggiorotto F, Valabrega G, Kubatzki F, Rossi V, Magistris A, Marocco F, Gatti M, Sarotto I, Aglietta M, Ponzone R.
    Ann Surg Oncol; 2012 Nov 01; 19(12):3755-61. PubMed ID: 22805871
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Survival outcomes in node-negative breast cancer patients evaluated with complete axillary node dissection versus sentinel lymph node biopsy.
    Cox C, White L, Allred N, Meyers M, Dickson D, Dupont E, Cantor A, Ly Q, Dessureault S, King J, Nicosia S, Vrcel V, Diaz N.
    Ann Surg Oncol; 2006 May 01; 13(5):708-11. PubMed ID: 16538416
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 42.